Biomarker Sciences Program

The Biomarker Sciences Program exists to support the clinical research of the two other scientific programs in the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). This program contains five scientific groups, by specialty: the Data Science Committee, Developmental Therapeutics Committee, Imaging Diagnostics and Biomarker Committee, Laboratory Science and Pathology Committee, and Pharmacogenomics Committee. Together, researchers in this program:

  • Evaluate and integrate cross-cutting biologic science opportunities
  • Attract basic and translational science from member and external organizations
  • Foster translational and correlative science across the Group

The Biomarker Steering Committee, shown below, guides the program and the cross-committee interactions among researchers.

Biomarker Steering Committee



Co-Chair

Represents the program as a deputy chair on the Executive Committee

Co-Chair

Co-Chair

Co-Chair

Keith T. Flaherty, MD

Harvard University, the Dana-Farber/Harvard Cancer Center, and the Massachusetts General Hospital Cancer Center
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 

Stanley R. Hamilton, MD

City of Hope Comprehensive Cancer Center
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 

David A. Mankoff, MD, PhD

University of Pennsylvania and the Abramson Cancer Center
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 

Anthony F. Shields, MD, PhD

Wayne State University and the Barbara Ann Karmanos Cancer Institute
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 
ECOG-ACRIN Cancer Research Group